2017
DOI: 10.5455/apd.256509
|View full text |Cite
|
Sign up to set email alerts
|

Aripiprazole and fluoxetine in the treatment of delusional parasitosis: a case report

Abstract: _____________________________________________________________________________________________________ ÖZ

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 7 publications
0
1
0
Order By: Relevance
“…[27] Recently, several case reports on the use of aripiprazole in the treatment of DD have been published. [28][29] [30][31] [32] Aripiprazole, a third-generation antipsychotic (TGA) that differs from SGA for its partial D2 agonist properties, is effective and well-tolerated in the treatment of psychosis in schizophrenia spectrum disorders as well as in other mental illnesses with predominant hallucinations, including obsessive-compulsive disorder, olfactory reference syndrome. [1] [33] Given the poor response to pharmacological treatment of DD, evidence-based treatment is needed.…”
Section: Introductionmentioning
confidence: 99%
“…[27] Recently, several case reports on the use of aripiprazole in the treatment of DD have been published. [28][29] [30][31] [32] Aripiprazole, a third-generation antipsychotic (TGA) that differs from SGA for its partial D2 agonist properties, is effective and well-tolerated in the treatment of psychosis in schizophrenia spectrum disorders as well as in other mental illnesses with predominant hallucinations, including obsessive-compulsive disorder, olfactory reference syndrome. [1] [33] Given the poor response to pharmacological treatment of DD, evidence-based treatment is needed.…”
Section: Introductionmentioning
confidence: 99%